Evidence map›Paper›PMID 36553324›Full record

ReviewChildren (Basel, Switzerland)2022

The Use of Psychotropic Medication in Pediatric Oncology for Acute Psychological and Psychiatric Problems: Balancing Risks and Benefits.

Johanna M C Blom, Elena Barisone, Marina Bertolotti, Daniela Caprino, Monica Cellini, Carlo Alfredo Clerici, Chiara Colliva, Cinzia Favara-Scacco, Silvia Di Giuseppe, Momcilo Jankovic and 7 more

Open access · goldAbstract readReview
In one paragraph

Review in Children (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The role of the mental health nurse in pediatric hematology-oncology - Part 1: Developing an innovative practice.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2024
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 2 countries.

Johanna M C BlomDepartment of Biomedical, Metabolic and Neural Sciences, School of Medicine, University of Modena, 41125 Modena, Italy.ORCID 0000-0002-4974-1964
Elena BarisonePediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria, Città Della Salute-OIRM, 102126 Turin, Italy.
Marina BertolottiPediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria, Città Della Salute-OIRM, 102126 Turin, Italy.
Daniela CaprinoPediatric Hematology and Oncology, Institute Giannina Gaslini, 16147 Genoa, Italy.
Monica CelliniDepartment of Pediatric Oncology, Azienda Ospedaliero-Universitaria Policlinco di Modena, 41125 Modena, Italy.
Carlo Alfredo ClericiDepartment of Hematology and Oncology, University of Milan, 20126 Milan, Italy.
Chiara CollivaLocal Health Unit of Modena, District of Carpi, 41012 Carpi, Italy.
Cinzia Favara-ScaccoA.O: U. Policlinico-San Marco Psychotherapy & LAD ONLUS, 95123 Catania, Italy.
Silvia Di GiuseppeCenter for Pediatric Hemato-Oncology, Marche Polytechnic University, 61100 Ancona, Italy.
Momcilo JankovicPaeditric Clinic, Universityof Milano-Bicocca, Fondazione MBBM, 20900 Monza, Italy.ORCID 0000-0001-9773-0576
Alessia PancaldiDepartment of Pediatric Oncology, Azienda Ospedaliero-Universitaria Policlinco di Modena, 41125 Modena, Italy.
Luca PaniDepartment of Biomedical, Metabolic and Neural Sciences, School of Medicine, University of Modena, 41125 Modena, Italy.ORCID 0000-0001-9273-2839
Geraldina PoggiScientific Institute, IRCCS E. Medea, Bosisio Parini, 23842 Lecco, Italy.
Veronica RiviDepartment of Life Science, University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0002-8413-4510
Fabio TasceddaCenter for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0002-3422-004X
Riccardo TortaDepartment of Neuroscience, University of Turin, 10124 Turin, Italy.
Dorella ScarponiUnità Operativa Pediatria Pession, IRSSC S. Orsola, 40138 Bologna, Italy.
University of Modena and Reggio Emilia · ITAzienda Ospedaliero-Universitaria di Modena · ITOspedale Sant'Anna · ITAzienda Unita' Sanitaria Locale Di Modena · ITIRCCS Eugenio Medea · ITIstituto Giannina Gaslini · ITMarche Polytechnic University · ITUniversity of Milan · ITUniversity of Milano-Bicocca · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute behavioral and emotional problems represent one of the most serious treatment-related adverse effects for children and adolescents who have cancer. The critical and severe nature of these symptoms often makes necessary the use of psychotropic drugs. A working group composed of experts in multiple disciplines had the task of creating an agreement regarding a management plan for severe acute behavioral and emotional problems (SABEPs) in children and adolescents treated for cancer. To obtain global information on the use of psychotropic drugs in pediatric oncology, the working group first developed and mailed a 15-item questionnaire to many Italian pediatric oncology centers. Overall, an evident lack of knowledge and education regarding the use of psychotropic medications for the treatment of SABEPs was found. Thus, by referring to an adapted version of the Delphi method of consensus and standard methods for the elaboration of clinical questions (PICOs), the working group elaborated evidence-based recommendations for psychotropic drugs in the pediatric oncology setting. Furthermore, based on a thorough multivariate analysis of needs and difficulties, a comprehensive management flow was developed to optimize therapeutic interventions, which allows more accurate and efficient matching of the acute needs of patients while guiding treatment options.

Indexed as

antidepressantmental healthpediatric oncologypsychotropic drugs

Identifiers

PMID36553324
PMCPMC9777172
OpenAlexW4311051481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.